CCL17 and CCL22 chemokines are upregulated in human obesity and play a role in vascular dysfunction.

Hueso, Luisa; Marques, Patrice; Morant, Brenda; Gonzalez-Navarro, Herminia; Ortega, Joaquin; Real, José T; Sanz, María J; Piqueras, Laura

Hueso, Luisa; Marques, Patrice; Morant, Brenda; Gonzalez-Navarro, Herminia; Ortega, Joaquin; Real, José T; Sanz, María J; Piqueras, Laura.

Affiliation

Hueso L; INCLIVA Biomedical Research Institute, Valencia, Spain.
Marques P; INCLIVA Biomedical Research Institute, Valencia, Spain.
Morant B; INCLIVA Biomedical Research Institute, Valencia, Spain.
Gonzalez-Navarro H; INCLIVA Biomedical Research Institute, Valencia, Spain.
Ortega J; Department of Biochemistry, University of Valencia, Valencia, Spain.
Real JT; CIBERDEM: Diabetes and Associated Metabolic Diseases Networking Biomedical Research- Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Sanz MJ; Surgery Service, University Clinic Hospital of Valencia, Valencia, Spain.
Piqueras L; Department of Surgery, University of Valencia, Valencia, Spain.

Front Endocrinol (Lausanne) ; 14: 1154158, 2023.

Article de En | MEDLINE | ID: mdl-37124725

Sujet(s)
Mots clés

CCL17; CCL22; adipose tissue; chemokines; endothelium; inflammation; obesity

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Obésité morbide / Cellules endothéliales Type d'étude: Prognostic_studies Limites: Adult / Humans / Middle aged Langue: En Journal: Front Endocrinol (Lausanne) Année: 2023 Type de document: Article Pays d'affiliation: Espagne Pays de publication: Suisse

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google